Communication between gastrointestinal bacteria and the nervous system

Typeset version

 

TY  - JOUR
  - Bravo, JA,Julio-Pieper, M,Forsythe, P,Kunze, W,Dinan, TG,Bienenstock, J,Cryan, JF
  - 2012
  - January
  - Current Opinion In Pharmacology
  - Communication between gastrointestinal bacteria and the nervous system
  - Validated
  - ()
  - IRRITABLE-BOWEL-SYNDROME ANXIETY-LIKE BEHAVIOR GUT-BRAIN COMMUNICATION LACTOBACILLUS-REUTERI GERM-FREE MATERNAL SEPARATION MICE BIFIDOBACTERIUM MICROBIOTA RATS
  - 12
  - 667
  - 672
  - In the past few years, intestinal microbiota has emerged as a novel target for the treatment of gut-brain axis alterations. These include functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), which can be comorbid with stress-related psychiatric conditions. Thus, modulation of the microbiota (e.g. with the use of probiotics) could be proposed as a novel strategy not only for the treatment of IBS but also as an adjuvant for psychiatric treatment of anxiety and depression.
  - DOI 10.1016/j.coph.2012.09.010
DA  - 2012/01
ER  - 
@article{V206308170,
   = {Bravo,  JA and Julio-Pieper,  M and Forsythe,  P and Kunze,  W and Dinan,  TG and Bienenstock,  J and Cryan,  JF },
   = {2012},
   = {January},
   = {Current Opinion In Pharmacology},
   = {Communication between gastrointestinal bacteria and the nervous system},
   = {Validated},
   = {()},
   = {IRRITABLE-BOWEL-SYNDROME ANXIETY-LIKE BEHAVIOR GUT-BRAIN COMMUNICATION LACTOBACILLUS-REUTERI GERM-FREE MATERNAL SEPARATION MICE BIFIDOBACTERIUM MICROBIOTA RATS},
   = {12},
  pages = {667--672},
   = {{In the past few years, intestinal microbiota has emerged as a novel target for the treatment of gut-brain axis alterations. These include functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), which can be comorbid with stress-related psychiatric conditions. Thus, modulation of the microbiota (e.g. with the use of probiotics) could be proposed as a novel strategy not only for the treatment of IBS but also as an adjuvant for psychiatric treatment of anxiety and depression.}},
   = {DOI 10.1016/j.coph.2012.09.010},
  source = {IRIS}
}
AUTHORSBravo, JA,Julio-Pieper, M,Forsythe, P,Kunze, W,Dinan, TG,Bienenstock, J,Cryan, JF
YEAR2012
MONTHJanuary
JOURNAL_CODECurrent Opinion In Pharmacology
TITLECommunication between gastrointestinal bacteria and the nervous system
STATUSValidated
TIMES_CITED()
SEARCH_KEYWORDIRRITABLE-BOWEL-SYNDROME ANXIETY-LIKE BEHAVIOR GUT-BRAIN COMMUNICATION LACTOBACILLUS-REUTERI GERM-FREE MATERNAL SEPARATION MICE BIFIDOBACTERIUM MICROBIOTA RATS
VOLUME12
ISSUE
START_PAGE667
END_PAGE672
ABSTRACTIn the past few years, intestinal microbiota has emerged as a novel target for the treatment of gut-brain axis alterations. These include functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), which can be comorbid with stress-related psychiatric conditions. Thus, modulation of the microbiota (e.g. with the use of probiotics) could be proposed as a novel strategy not only for the treatment of IBS but also as an adjuvant for psychiatric treatment of anxiety and depression.
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URL
DOI_LINKDOI 10.1016/j.coph.2012.09.010
FUNDING_BODY
GRANT_DETAILS